Grifols (GIKLY) Cash from Operations (QoQ) (2010 - 2020)

Grifols (GIKLY) Cash from Operations (QoQ) (2010 - 2020) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Grifols - - -

Historic Data

Download Data
DateValue
Mar 31, 2020 -69.02%
Mar 31, 2019 -140.86%
Jun 30, 2018 63.97%
Mar 31, 2018 -83.05%
Jun 30, 2017 65.53%
Mar 31, 2017 -20.48%
Dec 31, 2016 -15.29%
Dec 31, 2015 74.54%
Sep 30, 2015 -20.91%
Jun 30, 2015 539.25%
Mar 31, 2013 -40.83%
Dec 31, 2012 23.34%
Sep 30, 2012 -39.35%
Jun 30, 2012 263,219.29%
Mar 31, 2012 -99.95%
Dec 31, 2011 242.79%
Sep 30, 2011 261.53%
Jun 30, 2011 -164.95%
Mar 31, 2011 35.63%
Dec 31, 2010 168.13%